Humana to buy back $750M in stocks

Health insurance and services provider Humana has announced it will accelerate stock repurchase of $750 million.

The move is part of an accelerated stock repurchase agreement with Goldman Sachs & Co. to repurchase $3 billion, which was previously announced in December 2017. The repurchase is expected to be funded through a combination of parent cash and debt financing.

The number of shares in the buyback will depend on the share price of Humana common stock over the term of the agreement. Final settlement will occur in the first quarter of 2019, according to Humana.

The announcement comes after Humana made significant strides in its shift to value-based care over the last year. The company released its value-based care report in November, revealing big gains in its Medicare Advantage membership and transition away from fee-for-service among its physicians.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.